bpc-157 fda status approval 2025 or 2026 BREAKING: The just reversed theIR 2023 peptide ban. 12 peptides were just pulled from the Category 2 restricted list: 1. 2. Thymosin beta-4 fragment (TB-500) 3. Epitalon 4. GHK-Cu (injectable) Survey: Half of Peptide-Users Aren't

Peptides, BPC-157, and the Mainlining of Pseudoscientific Nonsense 30 years of rat-research and an avalanche of un-earned hype is coming to your clinic Critical Commentary takes a deep dive into one argument on a systemic problem in autoimmune drug development - trial design, regulatory strategy, industry incentives, or the gap between evidence and practice

The FDA is unequivocal that "retatrutide and cagrilintide cannot be used in compounding under federal law." "These are not components of FDA-approved drugs and have not been found safe and effective for any condition," the agency said in drug safety information posted online

Metabolic benefits from Sirt1 and Sirt1 activators

Effect of the probiotic strain Bifidobacterium animalis subsp.lactis, BB-12, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: A randomised, double- blind, placebo-controlled, parallel-group trial